InsidersTradesSigma
Follow the PACIFIC EDGE LIMITED stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the authority of ASX. Market capitalisation: €254.6m. The latest transaction was disclosed on 24 August 2026 (Other). All data is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 22,842 of 29,063 companies
31.7
score / 100
Value14
Quality50
FCF yld-13%
Earn yld-14%
EV/EBITDA·
ROE-195%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 August 2026
About PACIFIC EDGE LIMITED
PACIFIC EDGE LIMITED is a company listed on the Australian Securities Exchange, specializing in the development of diagnostic tests for cancer. It focuses on improving patient outcomes through innovative health solutions.